price
HY
OTC · HYBT
Heyu Biological Technology Corporation
Healthcare · Medical - Devices
$0.35
Down-$0.25 (-41.67%)
Updated Aug 17, 2026, 12:09 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 361.36M
- P/E ratio
- 468.55
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 370
- Avg. volume
- 2.61K
Price performance
HYBT price history
1M range · 0 trading sessions · Daily adjusted prices
HYBT does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest HYBT news
The latest Smart Investors Daily articles mentioning HYBT.
Stock researchCompany · Overview
HYBT research
Overview
Company profile and research snapshot.
Company profile
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.